BLIS Technologies

A biotechnology company, BLIS commenced business in August 2000 when it acquired from the University of Otago, rights to Salivaricin B, a substance which acts as a natural antibiotic to control streptococcal throat infections. Since that time, it has acquired the University's collection of several thousand BLIS (bacteriocin-like-inhibitory substances) producing organisms collected over a 25-year period by Prof John Tagg, now a consultant to the company.

Company Details

Registered Office: Ground Floor, 442 Moray Place, Dunedin 9016

Postal Address: Ground Floor, 442 Moray Place, Dunedin 9016

Telephone: +64-347-41338

Facsimile: n/a

Website: http://www.blis.co.nz/

First Listed: 30/07/2001

Balance Date: 31 March

AGM: 21/07/2022

Directors and Executives

Jorn Andreas

Director

Antony Balfour

Independent Director

Geoff Plunket

Chair

Barry Richardson

Independent Director

Dr Alison Stewart

Independent Director

Brian Watson

Chief Executive Officer

Richard Wingham

Chief Financial Officer

Announcements

Title	Date	Type
New Distribution Partner for NZ Pharmacy Channel	Fri, May 17 2024 03:00 pm	MKTUPDTE
Upgraded FY24 earnings guidance	Mon, Apr 15 2024 08:30 am	MKTUPDTE
D&O Ongoing Disclosure Notice	Fri, Mar 22 2024 01:59 pm	SHINTR
Capital change notice	Fri, Mar 22 2024 01:59 pm	SECISSUE
Revenue Growth and Profitable Third Quarter	Fri, Feb 23 2024 08:30 am	MKTUPDTE
D&O Initial Disclosure	Thu, Jan 18 2024 11:55 am	SHINTR
Director announcement	Mon, Dec 11 2023 10:20 am	ADMIN
New Chief Executive Appointed	Tue, Nov 28 2023 02:30 pm	ADMIN
Growth of B2B customer base in challenging conditions	Thu, Nov 16 2023 08:30 am	HALFYR
icensing agreement with Emma Lewisham	Tue, Oct 03 2023 08:41 am	MKTUPDTE

Major Holdings Announcements

Date	Name	No. Held	%	Current
28/02/23	Roger Norman Macassey and Mark Andr	142,213,158	-	11.16
07/07/21	Probi Aktiebolag	166,148,034	-	13.04
18/05/20	Wen Yi	53,280,077	5.83	4.81
27/03/18	W. Wu	-	6.83	-
06/03/17	Edinburgh Equity Limited	31,157,388	5.59	2.81
08/02/17	Mingchun Qiu	39,000,000	5.50	3.52

Director’s Interests Announcements

Date	Name	No. Held	%	Details	Other
25/03/22	Brian David Watson	4,730,431	-	-	-
09/03/20	Anthony Paul Offen	31,157,388	-	-	-
06/03/20	Alison Stewart	350,000	-	-	-
11/04/19	Geoffrey Phil Plunket	800,000	-	-	-
05/04/19	Alison Barrass	200,000	-	-	-
03/08/18	Barry Charles Richardso 17,903,625	-	-		-
01/12/16	Timothy James Mepham	55,977	0.01	-	-

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.

Last Updated: 01/05/2023